Our Services
Medical Information
Helpful Resources
Published on: 2/28/2026
Rexulti is an add-on to your antidepressant that fine-tunes serotonin and dopamine, often improving motivation, energy, and mood when there is only a partial response; clinical trials show greater symptom relief than an antidepressant alone. There are several factors to consider, including timing and side effects, and the complete details are below.
Medically approved next steps include confirming the diagnosis, optimizing or switching your antidepressant, considering adjuncts like Rexulti or alternatives, adding evidence-based therapy, and addressing sleep, activity, and alcohol use, with urgent symptoms needing immediate care; full guidance is below.
If you're still struggling with depression even after trying treatment, you're not alone. Many people don't feel full relief from their first antidepressant. That doesn't mean treatment has failed — it means your brain may need a different approach.
One option doctors often consider is Rexulti (brexpiprazole). Below, we'll explain how Rexulti works, who it may help, what to expect, and what medically approved next steps you can take if you're still not feeling like yourself.
Rexulti (brexpiprazole) is a prescription medication approved by the FDA for:
For depression, Rexulti is not usually used by itself. It's added to an existing antidepressant to help improve response. This is called adjunctive treatment.
Antidepressants (like SSRIs or SNRIs) mainly work on serotonin and sometimes norepinephrine. While effective for many, they don't fully relieve symptoms for everyone.
You might still experience:
This is sometimes called incomplete response or treatment-resistant depression.
It's common — and treatable.
Rexulti works in a unique way compared to traditional antidepressants.
It acts as a serotonin-dopamine activity modulator, which means:
In simpler terms:
Rexulti helps "fine-tune" brain signaling rather than simply increasing one chemical.
Why does that matter?
Depression isn't just about low serotonin. Dopamine — the brain chemical involved in motivation and pleasure — also plays a major role. By affecting both systems, Rexulti may help improve:
Clinical trials show that adding Rexulti to an antidepressant can improve depressive symptoms more than an antidepressant alone in people who haven't responded fully.
Doctors may consider Rexulti if you:
Rexulti is not usually a first-line treatment for depression. It's typically added when standard therapy hasn't been enough.
Rexulti is usually started at a low dose and gradually increased. This helps reduce side effects.
Some people notice improvements within a few weeks, but full benefits may take 4–8 weeks.
Like all medications, Rexulti has potential side effects. The most common include:
Less common but more serious risks can include:
Your doctor will monitor for these. Do not stop Rexulti suddenly without medical guidance.
If you experience severe side effects or thoughts of harming yourself, seek medical care immediately.
If you're not feeling better — or not better enough — here are evidence-based next steps doctors commonly recommend:
Sometimes symptoms overlap with:
Accurate diagnosis matters.
If you're unsure whether your symptoms align with major depressive disorder or another condition, Ubie's free AI-powered Depression symptom checker can help you identify what you're experiencing and guide your conversation with a healthcare provider.
Before adding Rexulti, doctors may:
If you've had partial response, adding Rexulti is a common next step supported by clinical trials.
This approach is often effective because it targets additional brain pathways beyond serotonin alone.
Other medically approved add-on treatments include:
Your doctor will tailor treatment to your medical history and symptom pattern.
Medication works best when combined with therapy.
Evidence-based therapies include:
If you're on medication but not in therapy, adding it may significantly improve results.
These aren't "quick fixes," but they matter:
Lifestyle changes don't replace medication when depression is moderate to severe — but they enhance results.
Depression can become serious. Speak to a doctor immediately or seek emergency care if you experience:
These symptoms require urgent medical attention.
Even if symptoms don't feel urgent, it's important to speak to a doctor about ongoing depression. Untreated depression can affect relationships, work, physical health, and long-term well-being.
No medication "cures" depression. But Rexulti can significantly reduce symptoms when added to an antidepressant.
For many people, the goal is:
Some people need medication short-term. Others may need longer-term treatment. That decision should always be made with your healthcare provider.
If you're still struggling, it does not mean:
Depression is a medical condition involving complex brain chemistry and life stressors. Sometimes it takes adjusting treatment to find the right combination.
Rexulti works differently than standard antidepressants, which is why it can help when others haven't fully worked.
But medication is only one part of the solution. Diagnosis review, therapy, medical monitoring, and lifestyle factors all matter.
If your current antidepressant isn't enough, adding Rexulti is a medically approved, evidence-based next step many doctors use successfully.
Here's what you can do today:
Depression is treatable. But it requires active management.
If anything feels severe, life-threatening, or unsafe, seek emergency care immediately and speak to a doctor right away.
You deserve real relief — not just partial improvement.
(References)
* Ishigaki, S., & Miyamoto, S. (2017). Brexpiprazole: A New Serotonin-Dopamine Activity Modulator. *Pharmaceuticals (Basel, Switzerland)*, *10*(3), 57.
* Iqbal, F. R., & Rahman, A. (2018). Brexpiprazole in the Treatment of Major Depressive Disorder: An Overview of Clinical Trial Data. *Clinical Drug Investigation*, *38*(7), 613–622.
* Citrome, L. (2015). Brexpiprazole: a new therapeutic option for schizophrenia. *Expert Review of Neurotherapeutics*, *15*(8), 861–871.
* Kane, J. M., & Citrome, L. L. (2018). Managing Residual Symptoms and Relapse in Patients With Schizophrenia: The Role of Brexpiprazole. *The Journal of Clinical Psychiatry*, *79*(3), 17ad11894.
* Thase, M. E., Youakim, J. M., & Hobart, M. (2017). Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: Review of Efficacy and Safety. *Current Drug Targets*, *18*(9), 1014–1026.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.